The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(tert-Butyl)-4-[1-(2-fluorophenyl)-1H-1,2,3-triazol-4-yl]-3,6-dihydropyridine-1(2H)-carboxamide ID: ALA461034
PubChem CID: 44588428
Max Phase: Preclinical
Molecular Formula: C18H22FN5O
Molecular Weight: 343.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)NC(=O)N1CC=C(c2cn(-c3ccccc3F)nn2)CC1
Standard InChI: InChI=1S/C18H22FN5O/c1-18(2,3)20-17(25)23-10-8-13(9-11-23)15-12-24(22-21-15)16-7-5-4-6-14(16)19/h4-8,12H,9-11H2,1-3H3,(H,20,25)
Standard InChI Key: VOFZVGRAKOZVJU-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
-4.7353 -1.5051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0209 -1.0926 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.3064 -1.5051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3064 -2.3301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0209 -2.7426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7353 -2.3301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0209 -0.2676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7353 0.1449 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0209 -3.5676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6883 -4.0525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.4334 -4.8372 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6084 -4.8372 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.3534 -4.0525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1235 -5.5046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3030 -5.4184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8181 -6.0858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1536 -6.8395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9741 -6.9257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4590 -6.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3064 0.1449 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.3064 0.9699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3064 1.7949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4814 0.9699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1314 0.9699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9674 -4.6647 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12 13 1 0
13 9 2 0
5 9 1 0
2 7 1 0
14 15 2 0
1 2 1 0
15 16 1 0
7 8 2 0
16 17 2 0
9 10 1 0
17 18 1 0
1 6 1 0
18 19 2 0
19 14 1 0
12 14 1 0
2 3 1 0
7 20 1 0
3 4 1 0
20 21 1 0
4 5 1 0
21 22 1 0
5 6 2 0
21 23 1 0
10 11 2 0
21 24 1 0
11 12 1 0
15 25 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 343.41Molecular Weight (Monoisotopic): 343.1808AlogP: 3.00#Rotatable Bonds: 2Polar Surface Area: 63.05Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 2.75CX LogD: 2.75Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.91Np Likeness Score: -1.90
References 1. Ito S, Satoh A, Nagatomi Y, Hirata Y, Suzuki G, Kimura T, Satow A, Maehara S, Hikichi H, Hata M, Kawamoto H, Ohta H.. (2008) Discovery and biological profile of 4-(1-aryltriazol-4-yl)-tetrahydropyridines as an orally active new class of metabotropic glutamate receptor 1 antagonist., 16 (22): [PMID:18849168 ] [10.1016/j.bmc.2008.09.060 ]